HomeCompareGILD vs BBY

GILD vs BBY: Dividend Comparison 2026

GILD yields 2.34% · BBY yields 5.96%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BBY wins by $77.75M in total portfolio value
10 years
GILD
GILD
● Live price
2.34%
Share price
$136.34
Annual div
$3.19
5Y div CAGR
17.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.1K
Annual income
$1,614.90
Full GILD calculator →
BBY
BBY
● Live price
5.96%
Share price
$63.91
Annual div
$3.81
5Y div CAGR
73.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$77.78M
Annual income
$68,615,349.24
Full BBY calculator →

Portfolio growth — GILD vs BBY

📍 BBY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGILDBBY
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GILD + BBY cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GILD pays
BBY pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GILD
Annual income on $10K today (after 15% tax)
$198.88/yr
After 10yr DRIP, annual income (after tax)
$1,372.67/yr
BBY
Annual income on $10K today (after 15% tax)
$506.73/yr
After 10yr DRIP, annual income (after tax)
$58,323,046.85/yr
At 15% tax rate, BBY beats the other by $58,321,674.19/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GILD + BBY for your $10,000?

GILD: 50%BBY: 50%
100% BBY50/50100% GILD
Portfolio after 10yr
$38.90M
Annual income
$34,308,482.07/yr
Blended yield
88.19%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GILD right now

GILD
Analyst Ratings
37
Buy
20
Hold
1
Sell
Consensus: Buy
Price Target
$158.71
+16.4% upside vs current
Range: $105.00 — $180.00
Altman Z
4.1
Piotroski
8/9
BBY
Analyst Ratings
15
Buy
21
Hold
5
Sell
Consensus: Hold
Price Target
$77.89
+21.9% upside vs current
Range: $66.00 — $96.00
Altman Z
4.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GILD buys
0
BBY buys
0
No recent congressional trades found for GILD or BBY in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGILDBBY
Forward yield2.34%5.96%
Annual dividend / share$3.19$3.81
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR17.3%73.5%
Portfolio after 10y$29.1K$77.78M
Annual income after 10y$1,614.90$68,615,349.24
Total dividends collected$7.6K$77.02M
Payment frequencyquarterlyquarterly
SectorHealthcareConsumer Discretionary
Analyst consensusBuyHold
Analyst price target$158.71$77.89

Year-by-year: GILD vs BBY ($10,000, DRIP)

YearGILD PortfolioGILD Income/yrBBY PortfolioBBY Income/yrGap
1← crossover$10,974$274.45$11,734$1,034.32$760.00BBY
2$12,073$330.19$14,524$1,968.02$2.5KBBY
3$13,316$398.20$19,490$3,949.71$6.2KBBY
4$14,730$481.49$29,449$8,594.43$14.7KBBY
5$16,345$583.87$52,567$21,056.54$36.2KBBY
6$18,199$710.26$117,193$60,946.09$99.0KBBY
7$20,340$866.96$345,714$220,317.99$325.4KBBY
8$22,826$1,062.22$1,423,773$1,053,859.18$1.40MBBY
9$25,731$1,306.80$8,560,997$7,037,559.32$8.54MBBY
10$29,147$1,614.90$77,775,616$68,615,349.24$77.75MBBY

GILD vs BBY: Complete Analysis 2026

GILDHealthcare

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.

Full GILD Calculator →

BBYConsumer Discretionary

Best Buy Co., Inc. retails technology products in the United States and Canada. The company operates in two segments, Domestic and International. Its stores provide computing products, such as desktops, notebooks, and peripherals; mobile phones comprising related mobile network carrier commissions; networking products; tablets covering e-readers; smartwatches; and consumer electronics consisting of digital imaging, health and fitness, home theater, portable audio comprising headphones and portable speakers, and smart home products. The company's stores also offer appliances, such as dishwashers, laundry, ovens, refrigerators, blenders, coffee makers, and vacuums; entertainment products consisting of drones, peripherals, movies, music, and toys, as well as gaming hardware and software, and virtual reality and other software products; and other products, such as baby, food and beverage, luggage, outdoor living, and sporting goods. In addition, it provides consultation, delivery, design, health-related, installation, memberships, repair, set-up, technical support, and warranty-related services. The company offers its products through stores and websites under the Best Buy, Best Buy Ads, Best Buy Business, Best Buy Health, CST, Current Health, Geek Squad, Lively, Magnolia, Best Buy Mobile, Pacific Kitchen, Home, and Yardbird, as well as domain names bestbuy.com, currenthealth.com, lively.com, yardbird.com, and bestbuy.ca. As of January 30, 2022, it had 1,144 stores. The company was formerly known as Sound of Music, Inc. The company was incorporated in 1966 and is headquartered in Richfield, Minnesota.

Full BBY Calculator →
📬

Get this GILD vs BBY comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GILD vs SCHDGILD vs JEPIGILD vs OGILD vs KOGILD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.